Court Rules
All enforcement actions
SettlementCritical RiskMultistate

Multistate Generic Drug Price-Fixing Settlements: Consumer Compensation Plan

Glenmark, Lannett, Bausch, Apotex, Heritage, and EmcureSeptember 1, 2026New Jersey Attorney General

Penalty Amount

$96,500,000

Summary

New Jersey and a coalition of states and territories obtained preliminary approval for a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to raise drug prices. The settlements total approximately $96.5 million, and eligible consumers may submit claims for compensation.

Remedy

The manufacturers’ settlement funds, totaling approximately $96.5 million, are to be distributed through a claims process to eligible consumers who purchased certain generic drugs. The release does not specify individual consumer award amounts.

Monetary PenaltyConsumer Refunds

Contract Impact

This release concerns antitrust settlements, not a privacy enforcement action. In vendor, distribution, and other commercial agreements in the pharmaceutical supply chain, review antitrust compliance representations and covenants, restrictions on sharing competitively sensitive pricing or sales information, and protocols governing communications with competitors. Review employee training and escalation procedures for trade association meetings and other industry contacts; privacy, consent, and breach-notification clauses are not implicated by the facts described here.

Contract Search Terms

competitor communicationscompetitively sensitive informationpricing information exchangeprice-fixing prohibitionsales and market allocationantitrust compliance representationcompetitor meeting protocolsemployee antitrust training

Violation Types

Entity Details

Entity

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

Industry

Healthcare

Multistate Coalition

Official Sources

Source Evidence

Entity Name
"Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage’s parent company, Emcure"
Fine Amount
"totaling approximately $96.5 million"
Violation Description
"claims that those companies illegally conspired to raise the prices of generic drugs."
Event Date
"This month, the U.S. District Court for the District of Connecticut granted preliminary approval"
Is Multistate
"New Jersey and a coalition of 47 other states and territories"

Related Enforcement Actions

CT

Glenmark, Lannett, Bausch, Apotex, Heritage, and Emcure

Connecticut and a coalition of 47 other states and territories announced preliminary court approval of a plan to distribute funds from settlements with generic drug manufacturers accused of conspiring to inflate drug prices. The release does not give the date of the court’s preliminary approval, so the event date reflects the press release date.

NJ

Credit Acceptance Corporation (CAC)

$694.0M

New Jersey's Attorney General and Division of Consumer Affairs, along with 41 Attorneys General, reached a $694 million settlement with subprime auto lender Credit Acceptance Corporation over allegations it originated unaffordable loans its own systems predicted borrowers could not repay, employed aggressive debt-collection tactics, and failed to prevent deceptive vehicle-service contract and GAP product 'packing' by dealers. The multistate settlement stepped in after the CFPB permanently dropped its 2023 enforcement action against CAC in 2025. CAC will provide $60 million in cash restitution, $634 million in debt relief, an additional $15 million to the states, and implement injunctive lending reforms including loan off ramps, pre-loan disclosures, add-on packing safeguards, and a seven-year vehicle price cap. Note: this is a consumer-protection lending enforcement action, not a privacy matter; violation categories are best-fit mappings from the available taxonomy.

NJ

Match Group, Inc.

$650K

The New Jersey Attorney General and Division of Consumer Affairs announced that Match Group, Inc. will pay $650,000 and change its business practices to settle allegations that it misrepresented or failed to disclose its criminal background screening policies and practices to New Jersey users, violating the New Jersey Consumer Fraud Act and the Internet Dating Safety Act. Under a Consent Order, Match must accurately represent its screening policies, notify existing New Jersey members of updated disclosures within 150 days, and post clear and conspicuous disclosures and safety notifications about the limitations of criminal background screenings.

NJ

Amazon

On August 31, 2026, New Jersey Attorney General Jennifer Davenport and the Division of Consumer Affairs joined the FTC and a bipartisan coalition of 21 other states in suing Amazon, alleging that for over seven years the company secretly rigged its advertising auctions—converting advertised 'second price' auctions into first-price auctions with hidden 'soft reserve price' surcharges—overcharging more than 500,000 small- and medium-sized businesses and extracting tens of billions of dollars. The complaint alleges Amazon actively concealed the surcharges, gave false and misleading answers to advertisers who asked directly about the auction format, and applied inflated upcharges on high-volume shopping days like Prime Day and Black Friday. The lawsuit was just filed; no penalties or remedies have been imposed yet.

NJ

Meta Platforms, Inc.

A bipartisan coalition of state attorneys general led by New Jersey, California, Colorado, and Kentucky is taking Meta Platforms, Inc. to trial, alleging that Meta designed addictive features on Instagram and Facebook that harm minors' mental health, illegally collected data from children under 13 without the required protections under COPPA, and misled users about platform safety. Opening arguments begin August 18, 2026, in the U.S. District Court for the Northern District of California. No monetary penalty or final remedy has yet been imposed.

NJ

U.S. Department of Transportation

A coalition of 21 state attorneys general and Pennsylvania filed lawsuits against the Trump Administration, DOT, FMCSA, DHS, and AAMVA to prevent the unlawful demand for a database containing personal information of 17 million commercial driver's license holders. The lawsuits allege violations of federal privacy laws and the Administrative Procedure Act, and seek an emergency order to block the data transfer.